Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
about
Pregnancy Outcomes of Mothers with Detectable CMV-Specific IgM Antibodies: A Three-Year Review in a Large Irish Tertiary Referral Maternity HospitalUniversal newborn screening for congenital CMV infection: what is the evidence of potential benefit?Salivary biomarkers: toward future clinical and diagnostic utilitiesCongenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and preventionOral Biofluid Biomarker Research: Current Status and Emerging FrontiersQuantization and diagnosis of Shanghuo (Heatiness) in Chinese medicine using a diagnostic scoring scheme and salivary biochemical parameters.Congenital cytomegalovirus infection in Canada: Active surveillance for cases diagnosed by paediatriciansCongenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatmentDetection of AMA-M2 in human saliva: Potentials in diagnosis and monitoring of primary biliary cholangitisSymptomatic Congenital Cytomegalovirus Infection in Children of Seropositive WomenGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theGlucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment.Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens.MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection.Prevalence of congenital cytomegalovirus infection in Nigeria: a pilot study.Screening tests: a review with examplesComparison of saliva PCR assay versus rapid culture for detection of congenital cytomegalovirus infection.Human Cytomegalovirus Infection Dysregulates the Localization and Stability of NICD1 and Jag1 in Neural Progenitor Cells.Congenital cytomegalovirus infection: clinical outcomeAwareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, CanadaA faster immunofluorescence assay for tracking infection progress of human cytomegalovirus.Determining the prevalence of cytomegalovirus infection in a cohort of preterm infants.Priorities for CMV vaccine developmentMaternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.The "silent" global burden of congenital cytomegalovirus.Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpoxGenotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infectionPrevalence and clinical aspects of CMV congenital Infection in a low-income population.Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection.Congenital cytomegalovirus infection: new prospects for prevention and therapyScreening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study.Incidence and impact of CMV infection in very low birth weight infants.Cytomegalovirus in pregnancy and the neonate.Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection.Evolutionary-developmental perspectives on immune system interactions among the pregnant woman, placenta, and fetus, and responses to sexually transmitted infectious agents.Nucleic acid-based diagnostics for infectious diseases in public health affairs.How to use... neonatal TORCH testing.Desirability and feasibility of a vaccine against cytomegalovirus.
P2860
Q26773186-B398C1B1-D187-4FA3-8066-78E5EEED8DA2Q26824199-3A4C7320-B094-426A-A563-595DE221A3D3Q26851200-69261026-64E9-4070-BC00-28DC0294B0CBQ27024030-242E479F-A277-4452-BA83-356108CE9F4FQ28077072-C6804E5B-FE94-4FF6-9FD1-98D8091AD599Q30564418-DF128445-581E-43D1-B740-F0357A2A4731Q33413926-1D6DEFA0-4E8E-48AE-8E25-E95907EAEC85Q33568646-D39D5F78-6071-4F62-BE82-B45575A8B860Q33678116-CFAEA498-3DA4-4BBA-9267-13EDA6B6617EQ33780561-EECFF247-40E1-4220-936C-C7C946901B49Q34212799-B3896B89-0C8C-40BB-95D8-0885B1693DD8Q34625357-65FD9F39-6139-45AC-9383-86E1B18D011FQ34667953-6D4D8D51-C353-4D98-B60D-6A0C3901C773Q34736347-1BA3B8D9-A019-4ECC-AFDA-604821A0AA4AQ34991006-8AEEF14A-FF57-4894-8438-8D3A392CAA30Q35095390-F548DDBF-3551-4F40-A633-FCFF749F8BF1Q35156702-D48267FA-62A7-4AE6-AE32-F1184EB14798Q35317799-CFE33BE5-FCF1-4674-B028-7576E806C542Q35456732-13F736EB-3A64-431E-8F95-49A1883798CDQ35745353-529BD859-DBA7-42C7-8269-7805380D056AQ35753496-2268E387-754A-4EA5-A3AE-96D1166E4405Q35958109-16A21BC2-250C-4C50-9812-859B1176D357Q36055934-110419B1-8762-46F7-8F92-F57487E45621Q36104095-8C422289-65E2-476D-9099-A0900D74B546Q36216553-7A59B3FE-7928-4C51-8598-BC54DBC44B74Q36268583-F1BB1ABC-3350-4860-9DA9-0CEB0270A897Q36558293-5F72958A-68C5-4CFF-B6CE-0903694F32EDQ37043625-2FD20D94-8736-43F8-946B-37678CBCE023Q37203354-06C97AE3-67C1-481B-AB29-52AB584AA7DFQ37220902-EE27D7C6-0F99-4EB8-80E7-A2366DA9A0FBQ37252571-295183B1-AFD8-423E-95A2-ADCFBB1446C1Q37254183-0F41E23A-88D7-4D1D-AF83-C0BBB40F9645Q37598175-FC8570CC-06E5-4900-B61D-A18E6EDA6893Q37602489-D8401DD9-87E0-46A5-A113-600A9FCB90F3Q37643347-1199381C-5194-4ED3-BCA1-F467A4BC13E8Q37696737-753021EB-4BD1-4ADE-98D4-5115F8EFD316Q37913474-BFBC34D5-5DC6-44C9-9F3E-59CE4419D019Q38015738-94EC9AE9-5A58-4608-B2D1-E045020B411DQ38087436-18D3A25C-940F-423C-8847-CD867DD1ECC2Q38100041-44E3B036-DCB6-4C53-9FCE-DC82A851EB4E
P2860
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
@ast
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
@en
type
label
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
@ast
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
@en
prefLabel
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
@ast
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
@en
P2093
P2860
P356
P1476
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.
@en
P2093
Amina Ahmed
April L Palmer
David I Bernstein
Karen B Fowler
Marian G Michaels
Masako Shimamura
National Institute on Deafness and Other Communication Disorders CHIMES Study
Nazma Chowdhury
Pablo J Sánchez
Robert W Tolan
P2860
P304
P356
10.1056/NEJMOA1006561
P407
P577
2011-06-01T00:00:00Z